Radiopaque embolic particles

A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ abl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BOYD DANIEL, ABRAHAM ROBERT J, KEHOE SHARON
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM,RUBIDIUM, CAESIUM, OR FRANCIUM COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM,CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THERARE-EARTH METALS COMPOUNDS THEREOF HUMAN NECESSITIES HYGIENE INORGANIC CHEMISTRY MEDICAL OR VETERINARY SCIENCE METALLURGY NON-METALLIC ELEMENTS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A particulate material comprises 0.4 - 0.60 mole fraction SiO2; 0.04 - 0.7 mole fraction TiO2; 0.04 - 0.5 mole fraction La2O3; 0.03 - 0.3 mole fraction MgO; and 0.03 - 0.3 mole fraction Na2O. The particulate material is useful in the treatment of vascular occlusion, vascular malformations, organ ablation, chemoembolization, uterine fibroid embolization and haemorrhage.